Oncology & Cancer

Cervical vaccine also protects against anal cancer risk

A vaccine routinely used to shield against cervical cancer caused by the human papillomavirus also reduces women's risk of anal cancer, a study published by the journal The Lancet Oncology on Tuesday says.

Diseases, Conditions, Syndromes

Research team periodizes this history of virology development

A research team led by Associate Professor Liu Huan from the School of Humanities and Social Sciences of University of Science and Technology of China (USTC) proposes for the first time a historical periodization of the development ...

Health

Toolkit for reducing cervical cancer risk

Cervical cancer is the fourth most common cancer in women globally, particularly in low- and middle-income countries. In the U.S., cervical cancer is no longer a common cause of cancer death because of the use of a screening ...

page 37 from 40